Why Is Purdue Selling Oxycodone?

Documents released from the Kentucky suit as well as a lawsuit in Massachusetts paint a picture that puts Richard Sackler in the middle of Purdue's strategy to sell Oxycodone by lying about how strong it was. The strategy worked by gangbusters, netting the company $48 million in the first full year of sales. In an email to the company, Richard noted, clearly this strategy has outperformed our expectations, market research, and fondest dreams.